Induction of neutral endopeptidase (NEP) activity of SK-N-SH cells by natural compounds from green tea

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 4, 2006, Pages 495-501

  Ayoub, Shereen ^a   Melzig, Matthias F ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; AMYLOID BETA PROTEIN; BUCLADESINE; CAFFEINE; EPICATECHIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FORSKOLIN; GREEN TEA EXTRACT; MEMBRANE METALLOENDOPEPTIDASE; NATURAL PRODUCT; POLYPHENOL; ROLIPRAM; THEANINE; THEOBROMINE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BRAIN; CELL LEVEL; CELL LINE; CELL STRAIN SK N SH; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; LONG TERM CARE; NEUROBLASTOMA CELL; NEUROPATHOLOGY; PROTEIN DEGRADATION; SENILE PLAQUE; TEA;

CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; HUMANS; NEPRILYSIN; PLANT EXTRACTS; TEA;

EID: 33645562327     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.4.0009     Document Type: Article

References (37)

1. Ajiro, K., Shibata, K., Nishikawa, Y. (1990) Subtype-specific cyclic AMP-dependent histone H1 phosphorylation at the differentiation of mouse neuroblastoma cells. J. Biol. Chem. 265: 6494-6500
2. Axelrod, J., Reisenthal, J. (1953) The fate of caffeine in man and a method for its estimation in biological material. J. Pharmacol. 107: 519-523
3. Belibi, F. A., Wallace, D. P., Yamaguchi, T., Christensen, M., Reif, G., Grantham, J. J. (2002) The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 13: 2723-2729
4. Benzie, I. F., Szeto, Y. T., Strain, J. J., Tomlinson, B. (1999) Consumption of green tea causes rapid increase in plasma antioxidant power in humans. Nutr. Cancer 34: 83-87
5. Bormann, H., Melzig, M. F. (2000) Inhibition of metallopeptidase by flavonoids and related compounds. Pharmazie 55: 129-132
6. Brice, C. F., Smith, A. P. (2002) Effects of caffeine on mood and performance: a study of realistic consumption. Psychopharmacology 164: 188-192
7. Chen, C., Yu, R., Owuor, E. D., Kong, A. N. (2000) Activation of antioxidant-response element (ARE) and caspases by major green tea polyphenole components during cell survival and death. Arch. Pharm. Res. 23: 605-612
8. Dall'Igna, O. P., Porciuncula, L. O., Souza, D. O., Cunha, R. A., Lara, D. R. (2003) Neuroprotection by caffeine and adenosine A2A receptor blockade of β-amyloid neurotoxicity. Br. J. Pharmacol. 23: 5361-5369
9. Daly, J. W., Bruns, R. F., Snyder, S. H. (1981) Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines. Life Sci. 28: 2083-2097
10. Embola, C. W., Sohn, O. S., Fiala, E. S., Weisburger, J. H. (2002) Induction of UDP-glucuronyltransferase 1 (UDP-GT1) gene complex by green tea in male F344 rats. Food Chem. Toxicol. 40: 841-844
11. Fujiki, H. (1999) Two stages of cancer prevention with green tea. J. Cancer Res. Clin. Oncol. 125: 589-597
12. Graf, K., Kunkel, K., Zhang, M., Grafe, M., Schultz, K., Schudt, C., Biroc, S., Fleck, E., Kunkel, G. (1995) Activation of adenylate cyclase and phosphodiesterase inhibition enhance neutral endopeptidase activity in human endothelial cells. Peptides 16: 1273-1278
13. Graham, T. E., Spriet, L. L. (1995) Metabolic, catecholamine, and exercise performance responses to various doses of caffeine. J. Appl. Physiol. 78: 867-874
14. Haqqi, T. M., Anthony, D. D., Gupta, S., Ahmad, N., Lee, M. S., Kumar, G. K., Mukhtar, H. (1999) Prevention of collagen-induced arthritis in mice by polyphenolic fraction from green tea. Proc. Natl Acad. Sci. USA 96: 4524-4529
15. Hong, J. H., Ryu, S. R., Kim, H. J., Lee, S. H., Kim, D. B., Yun, Y. P., Ryu, J. H., Lee, B. M., Kim, P. Y. (2000) Neuroprotective effect of green tea extract in experimental ischemia-reperfumsion brain injury. Br. Res. Bull. 53: 743-749
16. Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C., Hama, E., Lee, H. J., Saido, T. C. (2001) Metabolic regulation of Abeta by neprilysin. Science 292: 1550-1552
17. Iwata, N., Higuchi, K., Saido, T. C. (2005) Metabolism of amyloid-beta peptide and Alzheimer's disease. Pharmacol. Ther. 108: 129-148
18. Labarca, C., Paigen, K. (1980) A simple, rapid and sensitive DNA assay procedure. Anal. Biochem. 102: 344-352
19. Lee, M. J., Maliakal, P., Chen, L., Meng, X., Bondoc, F. Y., Prabhu, S., Lambert, G., Mohr, S., Yang, C. S. (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans. Cancer Epidemiol. Biomarkers Prev. 11: 1025-1032
20. Maia, L., De Mendonca, A. (2002) Does caffeine intake protect from Alzheimer's disease? Eur. J. Neurol. 9: 377-382
21. Marr, R. A., Rockenstein, E., Mukherjee, A., Kindy, M. S., Hersh, L. B., Gage, F. H., Verma, I. M., Masliah, E. (2003) Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 23: 1992-1996
22. Melzig, M. F., Janka, M. (2003) Enhancement of neutral endopeptidase activity in SK-N-SH cells by green tea extract. Phytomedicine 10: 494-498
23. Nakagawa, K., Okuda, S., Miyazawa, T. (1997) Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci. Biotechnol. Biochem. 61: 1981-1985
24. Pearse, D. D., Pereira, F. C., Marcillo, A. E., Bates, M. L., Berrocal, Y. A., Filbin, M. T., Bunge, M. B. (2004) cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat. Med. 10: 610-616
25. Rago, R., Mitchen, J., Wilding, G. (1990) DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. Anal. Biochem. 191: 31-34
26. Rail, T. W. (1980) Central nervous system stimulants. The xanthines. In: Goodman, L. S., Gilman, A. (eds.) The pharmacological basis of therapeutics. 6th edn, MacMillan, New York, pp 592-607
27. Selkoe, D. J. (2001) Alzheimer's disease: genes, proteins and therapy. Physiol. Rev. 81: 741-766
28. Shirotani, K., Tsubuki, S., Iwata, N., Takaki, Y., Harigaya, W., Maruyama, K., Kiryu-Seo, S., Kiyama, H., Iwata, H., Tomita, T., Iwatsubo, T., Saido, T. C. (2001) Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J. Biol. Chem. 276: 21895-21901
29. Thong, F. S., Derave, W., Kiens, B., Graham, T. E., Urso, B., Wojtaszewski, J. F., Hansen, B. F., Richter, E. A. (2002) Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Diabetes 51: 583-590
30. Turner, A. J., Tanzawa, K. (1997) Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. Fed. Am. Soc. Exp. Biol. 11: 355-364
31. Uehara, C., Ino, K., Suzuki, T., Kajiyama, H., Kikkawa, F., Nagasaka, T., Mizutani, S. (2001) Up regulation of neutral endopeptidase expression and enzymatic activity during the differentiation of human choriocarcinoma cells. Placenta 22: 540-549
32. Vitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., Shelanski, M. (2002) Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl Acad. Sci. USA 99: 13217-13221
33. Wan Kim, S., Wan Kim, J., Chul Choi, K., Kwon Ma, S., Oh, Y., Jung, J. Y., Kim, J., Lee, J. (2004) Indomethacin enhances shuttling of aquaporin-2 despite decreased abundance in rat kidney. J. Am. Soc. Nephrol. 15: 2998-3005
34. Weisburger, J. H., Chung, F. L. (2002) Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. Food Chem. Toxicol. 40: 1145-1154
35. Wolozin, B., Lesch, P., Lebovics, R., Sunderland, T. (1993) Olfactory neuroblasts from Alzheimer donors: studies on APP processing and cell regulation. Biol. Psychiatry 34: 824-838
36. Yasojima, K., Akiyama, H., McGeer, E. G., McGeer, P. L. (2001a) Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci. Lett. 297: 97-100
37. Yasojima, K., McGeer, E. G., McGeer, P. L. (2001b) Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain. Brain Res. 919: 115-112